Company Filing History:
Years Active: 2025
Title: Claudio Fiorelli: Innovator in P2X3 Inhibitors
Introduction
Claudio Fiorelli is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors in the human body.
Latest Patents
Fiorelli holds a patent for "Amino quinazoline derivatives as P2X3 inhibitors." This invention relates to compounds that inhibit the P2X purinoceptor 3, which plays a crucial role in various physiological processes. The compounds are particularly useful in treating respiratory diseases such as cough, asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). His innovative work in this area has the potential to improve therapeutic options for patients suffering from these conditions.
Career Highlights
Claudio Fiorelli is associated with Chiesi Farmaceutici S.p.a., a prominent pharmaceutical company. His work there has focused on the development of new therapeutic agents that can address unmet medical needs. With a patent portfolio that includes 1 patent, Fiorelli has established himself as a key figure in pharmaceutical innovation.
Collaborations
Fiorelli has collaborated with notable colleagues such as Paolo Bruno and Matteo Biagetti. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Claudio Fiorelli's contributions to the field of pharmaceutical sciences, particularly through his patent on P2X3 inhibitors, highlight his role as an innovator. His work has the potential to significantly impact the treatment of various respiratory disorders.